Return to the Home Page

Go to this topic's parent

Go to the previous topic in the book structure

Go to the next topic in the book structure

Search the site

Sepsis

Sepsis is a medical emergency.

See Sepsis in Adults and Immunosuppressed Patients in Hospital HealthPathways.

Pathogens

Drug treatment

Go to this topic's parent

Search the site

Non-immunosuppressed sepsis without apparent source

If there are risk factors for immunosuppression, see immunosuppressed sepsis without apparent source.

Non-immunosuppressed sepsis without apparent source is divided into three sections:

Community-acquired

ceftriaxone

HMLSchedNZFPMLnoids

IV 2 g every 24 hours

 

If patient has hypotension and/or new organ dysfunction (two options based on CrCl):

CrCl ≥ 20 mL/min, ADD:

gentamicin

HMLSchedNZFPMLnoids

Single dose of IV 7 mg/kg ideal body weight. Round dose down to nearest half vial (40 mg). Consult Infectious Diseases/Clinical Microbiology before giving a second dose. See dosing/monitoring guidelines.

 

OR

CrCl < 20 mL, use monotherapy of:

piperacillin+tazobactam

HMLNZFPMLnoids

IV 4 g/500 mg every twelve hours

 

Severe penicillin allergy

meropenem

HMLNZFPMLnoids

IV 1 g every eight hours

Healthcare-associated

ceftriaxone

HMLSchedNZFPMLnoids

IV 2 g every 24 hours

 

If patient has hypotension and/or new organ dysfunction (two options based on CrCl):

CrCl ≥ 20 mL/min, ADD:

gentamicin

HMLSchedNZFPMLnoids

Single dose of IV 7 mg/kg ideal body weight. Round dose down to nearest half vial (40 mg). Consult Infectious Diseases/Clinical Microbiology before giving a second dose. See dosing/monitoring guidelines.

 

OR

CrCl < 20 mL, use monotherapy of:

piperacillin+tazobactam

HMLNZFPMLnoids

IV 4 g/500 mg every twelve hours

 

Severe penicillin allergy

meropenem

HMLNZFPMLnoids

IV 1 g every eight hours

ESBL-colonised in past 12 months

meropenem

HMLNZFPMLnoids

IV 1 g every eight hours

Go to this topic's parent

Search the site

Immunosuppressed sepsis without apparent source

If there are no risk factors for immunosuppression, see non-immunosuppressed sepsis without apparent source.

If ESBL-colonised in past 12 months, see separate guideline.

piperacillin+tazobactam

HMLNZFPMLnoids

IV 4 g/500 mg every six hours

 

If patient has hypotension and/or new organ dysfunction, ADD:

gentamicin

HMLSchedNZFPMLnoids

CrCl ≥ 20 mL/min:
Single dose of 7 mg/kg ideal body weight IV. Round dose down to nearest half vial (40 mg). Consult Infectious Diseases/Clinical Microbiology before giving a second dose. See dosing/monitoring guidelines.
 

CrCl < 20 mL/min:
Not recommended.

 

Mild penicillin allergy

cefepime

HMLNZFPMLnoids

IV 2 g every eight hours

 

If patient has hypotension and/or new organ dysfunction, ADD:

gentamicin

HMLSchedNZFPMLnoids

CrCl ≥ 20 mL/min:
Single dose of 7 mg/kg ideal body weight IV. Round dose down to nearest half vial (40 mg). Consult Infectious Diseases/Clinical Microbiology before giving a second dose. See dosing/monitoring guidelines.
 

CrCl < 20 mL/min:
Not recommended.

 

Severe penicillin allergy

meropenem

HMLNZFPMLnoids

IV 1 g every eight hours

Return to the Home Page

Topic Code: 99250